Back
Calvert US Mid-Cap Core Responsible Index ETF Vs. Akero Therapeutics Industry Stock Comparison
Buy
72
CVMC
Calvert US Mid-Cap Core Responsible Index ETF
Last Price:
$60.72
Seasonality Move:
0.62%
Sell
44
AKRO
Akero Therapeutics
Last Price:
$51.76
Seasonality Move:
45.38%
Buy
72
Calvert US Mid-Cap Core Responsible Index ETF (CVMC)
is a Buy
Is Calvert US Mid-Cap Core Responsible Index ETF a Buy, Sell or Hold?
-
The current Calvert US Mid-Cap Core Responsible Index ETF [CVMC] share price is $61.58. The Score for CVMC is 72, which is 44% above its historic median score of 50, and infers lower risk than normal.
-
CVMC is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
44
Akero Therapeutics (AKRO)
is a Sell
Is Akero Therapeutics a Buy, Sell or Hold?
-
The current Akero Therapeutics [AKRO] share price is $52.73. The Score for AKRO is 44, which is 12% below its historic median score of 50, and infers higher risk than normal.
-
AKRO is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
CVMC Stock Price Chart
What is Calvert US Mid-Cap Core Responsible Index ETF's stock price today?
-
The Calvert US Mid-Cap Core Responsible Index ETF share price today is $61.58The current trend is moderately bullish and CVMC is experiencing buying pressure, which is a positive indicator for future bullish movement.
AKRO Stock Price Chart
What is Akero Therapeutics's stock price today?
-
The Akero Therapeutics share price today is $52.73The current trend is moderately bearish and AKRO is experiencing slight buying pressure.
CVMC Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.72 | Buy |
| Relative Strength Index (14 RSI): | 61.82 | Buy |
| Chaikin Money Flow: | 2679 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (59.5 - 61.42) | Buy |
| Bollinger Bands (100): | (55.28 - 60.66) | Buy |
AKRO Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.37 | Buy |
| Relative Strength Index (14 RSI): | 53.6 | Buy |
| Chaikin Money Flow: | 120856 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (51.86 - 55.26) | Sell |
| Bollinger Bands (100): | (40.15 - 52.05) | Buy |
CVMC Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 61.65 | Sell |
| 20-day SMA: | 60.59 | Buy |
| 50-day SMA: | 59.52 | Buy |
| 200-day SMA: | 59.58 | Buy |
| 8-day EMA: | 61.48 | Buy |
| 20-day EMA: | 60.83 | Buy |
| 50-day EMA: | 59.64 | Buy |
| 200-day EMA: | 58.61 | Buy |
AKRO Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 51.62 | Buy |
| 20-day SMA: | 53.45 | Sell |
| 50-day SMA: | 49.34 | Buy |
| 200-day SMA: | 39.34 | Buy |
| 8-day EMA: | 52.09 | Buy |
| 20-day EMA: | 52.29 | Buy |
| 50-day EMA: | 49.9 | Buy |
| 200-day EMA: | 41.1 | Buy |
Calvert US Mid-Cap Core Responsible Index ETF Earnings Growth & CVMC Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Akero Therapeutics Earnings Growth & AKRO Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.02 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.18 per share, and a decrease next year of $0.64 per share.
Calvert US Mid-Cap Core Responsible Index ETF Technical Analysis
| Jun 30 | Jul 1 | Jul 2 | Jul 3 | Jul 7 | Jul 8 | Jul 9 | Jul 10 | Jul 11 | Jul 14 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun | Jul | |||||||||
| 30 | 01 | 02 | 03 | 07 | 08 | 09 | 10 | 11 | 14 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Akero Therapeutics Technical Analysis
| Jun 30 | Jul 1 | Jul 2 | Jul 3 | Jul 7 | Jul 8 | Jul 9 | Jul 10 | Jul 11 | Jul 14 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun | Jul | |||||||||
| 30 | 01 | 02 | 03 | 07 | 08 | 09 | 10 | 11 | 14 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||